SR One
VC / CVC · Redwood City, MA · United States
Etapas
Región de inversión
Industrias
Perfil
SR One is a venture capital firm with offices in Redwood City, California, and London, United Kingdom. The firm is led by Founder & CEO Simeon J. George, MD, and operates with a team experienced in healthcare and life sciences sectors. They are known for their transatlantic approach, leveraging continuity of experience to accelerate value creation across their investments. SR One predominantly invests in the life sciences sector, with a focus on biotechnology, pharmaceuticals, and healthtech. Their investment sizes typically range from $10-50 million, targeting Series A through late-stage rounds primarily in North America and Europe. Notable portfolio companies include Avalyn Pharma - focused on respiratory therapeutics, BioTheryX - working on protein modulation therapies, Palleon Pharmaceuticals - developing immune-oncology treatments, Poplar Therapeutics - specializing in immunotherapy, and Rezo Therapeutics - focusing on precision oncology.
Contactos (4)
| Nombre | Cargo | Teléfono | ||
|---|---|---|---|---|
| Principal | — | — | — | |
| President | ||||
| Venture Partner | — | — | — | |
| — | — |
El nombre, email y teléfono se muestran en sombra. Suscribite para verlos completos.